Government ContextGovernment Context
TopicsAgenciesOrganizationsDocumentsPricingLog inCreate account
TopicsAgenciesOrganizationsDocumentsPricing
LoginCreate account
Organizations › Amgen
A

Amgen

Business/org/amgen
Comments
5
Dockets
5
Support
4
Oppose
1

Activity

No recent organization activity yet. Historical comments remain available in the record.

Comment record

Recent public comments attributed to this organization.

  • Medicare and Medicaid Programs: Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, etc.
    Jun 29Support
  • AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for Information
    Jun 24Support
  • ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing
    Jun 11Oppose
  • Medicare Program: Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2027 Rates; Requirements for Quality Programs; and Other Policy Changes
    Jun 10Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgenciesOrganizations
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.